New product: Astra Zeneca COVID-19 Vaccine ((ChAdOx1 S [recombinant]) Temporary Authorisation
An SPC and PIL has now been published for this vaccine. As with any new medicine, healthcare professionals are asked to report any suspected adverse reactions.
Source:
electronic Medicines compendium